Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm

General Info

Geography

Denmark (DNK)

Finland (FIN)

Iceland (ISL)

Ireland (IRL)

Norway (NOR)

Sweden (SWE)

United Kingdom (GBR)

View all

Time period covered

January, 1998 - December, 2004

Data type

Scientific literature

Keywords

Heart failure, Ischemic heart disease, Peripheral vascular diseases, Stroke

Citation

Authors

Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O’Brien E, Ostergren J, ASCOT Investigators

Journal

Lancet

Pages

895–906

Publication year

2005

Suggested citation

Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O’Brien E, Ostergren J, ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm. Lancet. 2005; 366(9489): 895–906.